FDA approves Zilbrysq for generalized myasthenia gravis
The U.S. Food and Drug Administration has approved UCB' Zilbrysq (zilucoplan) for the treatment of adults with generalized myasthenia gravis. ...
Read moreDetailsThe U.S. Food and Drug Administration has approved UCB' Zilbrysq (zilucoplan) for the treatment of adults with generalized myasthenia gravis. ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info